000 | 01961 a2200589 4500 | ||
---|---|---|---|
005 | 20250515162903.0 | ||
264 | 0 | _c20090424 | |
008 | 200904s 0 0 eng d | ||
022 | _a1558-8238 | ||
024 | 7 |
_a10.1172/JCI38052 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLevy, Yves | |
245 | 0 | 0 |
_aEnhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. _h[electronic resource] |
260 |
_bThe Journal of clinical investigation _cApr 2009 |
||
300 |
_a997-1007 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 | _aCD4-CD8 Ratio |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 | _aDrug Tolerance |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 | _aHIV-1 |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunologic Memory |
650 | 0 | 4 |
_aInterleukin-7 _xadverse effects |
650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
650 | 0 | 4 |
_aLymphopenia _xdrug therapy |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
650 | 0 | 4 | _aSafety |
650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
700 | 1 | _aLacabaratz, Christine | |
700 | 1 | _aWeiss, Laurence | |
700 | 1 | _aViard, Jean-Paul | |
700 | 1 | _aGoujard, Cecile | |
700 | 1 | _aLelièvre, Jean-Daniel | |
700 | 1 | _aBoué, François | |
700 | 1 | _aMolina, Jean-Michel | |
700 | 1 | _aRouzioux, Christine | |
700 | 1 | _aAvettand-Fénoêl, Véronique | |
700 | 1 | _aCroughs, Thérèse | |
700 | 1 | _aBeq, Stéphanie | |
700 | 1 | _aThiébaut, Rodolphe | |
700 | 1 | _aChêne, Geneviève | |
700 | 1 | _aMorre, Michel | |
700 | 1 | _aDelfraissy, Jean-François | |
773 | 0 |
_tThe Journal of clinical investigation _gvol. 119 _gno. 4 _gp. 997-1007 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI38052 _zAvailable from publisher's website |
999 |
_c18726099 _d18726099 |